PAR
PARA BIO FPO [PAR]
Healthcare · ASX Small Cap
$0.2550 -1.9%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical38
Catalyst53
Sentiment50
Fundamental58
Momentum57
Risk Gate50
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Stochastic oversold
- Volatility contracting (breakout setup)
- Adequate cash runway (4 quarters)
- Pre-revenue with moderate cash ($10-30M)
- EPS estimates revised downward (-10pts)
- Near 52-week low (2% of range)
- Pre-revenue company — Altman Z-Score not applicable
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Negative 5-day momentum (-5.6%)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Appendix 4D and Half Year Report
NONE Change of Director's Interest Notice
NONE Change of Director's Interest Notice
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-26 | Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-23 | Change of Director's Interest Notice |
| 2026-02-23 | Change of Director's Interest Notice |
| 2026-02-19 | Notification regarding unquoted securities - PAR |
| 2026-02-18 | Notice under Section 708A |
Key Metrics
$114.2M
Market Cap
987K
Avg Volume
1.2x
Vol Ratio
$0.26 — $0.51
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
-81.7%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 80% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | weak | Inst: 6% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #70 of 119 · Sector avg: 51
View all Healthcare signals →